
IOVA FRAUD ALERT: Iovance Biotherapeutics 44% Stock Drop Triggers Securities Fraud Class Action – Investors Notified to ...
NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company’s senior executives for potential …